Blood-based testing
Quantitative tests assess liver health without invasive procedures.
HepQuant
Compiled from public sources
Unclaimed business
Unclaimed
- Claim to manage details & reply to reviews
- Pro profile & priority placement
- Reedleys Recognition & certificate
About HepQuant
HepQuant develops quantitative, blood-based tests that measure liver health, including liver cell processes and blood flow to the liver. Its HepQuant DuO test provides a Disease Severity Index to assess liver impairment and disease state. Healthcare providers can use results alongside other clinical assessments to help risk-stratify patients, inform treatment decisions, monitor therapy, and assess disease progression. Testing may also support evaluation of complications and decisions about invasive procedures. The company provides solutions for clinicians and drug developers, including use of its tests in clinical trials. Its specialty is noninvasive measurement of liver health and portal shunting. HepQuant is based in Denver, Colorado.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Category illustration. Illustrative image for this category. Not provided by the business.
Highlights
HepQuant DuO
Provides a Disease Severity Index for liver impairment.
Clinical research
Offers test applications for drug developers and clinical trials.
HepQuant Reviews
No reviews yet — be the first to review HepQuant.
Write a review
Sign in to write a review
or get a one-click link by email
No password needed. We only use your email to confirm the review is genuine.